title: [Cannabinoids in medicine].
abstract: Cannabinoids have been known for many centuries because of their various effects in healthcare. They are primarily effective in reducing nausea, vomiting, pain, anorexia, spasticity and depression. Some other effects are known, all seem to be mediated by cannabinoid receptors in the central nervous system. In the past years, medical use has been proven in several studies. Today, the therapeutical use of cannabinoids in medicine is increasing, and access was made easier. Especially in pain-management and palliative care, they seem to be a valuable therapeutic option.
authors.affiliation: rita.lenk@gmx.at
authors.forename: Rita
authors.initials: R
authors.lastname: Lenk
authors.forename: Rudolf
authors.initials: R
authors.lastname: Likar
mesh_terms: D000230:Adenocarcinoma / Q000503:physiopathology* / Q000523:psychology; D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D013759:Dronabinol / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology / Q000523:psychology; D010148:Intractable Pain / Q000188:drug therapy* / Q000523:psychology; D010166:Palliative Care / Q000379:methods*; D011788:Quality of Life / Q000523:psychology; D014594:Uterine Neoplasms / Q000503:physiopathology* / Q000523:psychology
chemical_list: D000700:Analgesics; D000701:Analgesics, Opioid; C011941:nabilone; D013759:Dronabinol